Memoplant Tablets p / o, 80 mg, # 30

Memoplant tab.

p / o captivity.

80mg No. 30

Name ENG

MEMOPLANT

Clinical and pharmacological group

Phytopreparation that improves cerebral and peripheral circulation

ATX code

Ginkgo biloba

Dosage

80mg

Structure

Active ingredient: Ginkgo biloba leaf extract dry EGb761® (35–67: 1) 120 mg, extractant - acetone 60% (standardized for the content of ginkgoflavone glycosides - 28.8 mg and terpenlactones - 7.2 mg)

Excipients: lactose monohydrate - 68.25 mg

colloidal silicon dioxide - 3 mg

MCC - 163.5 mg

corn starch - 15 mg

croscarmellose sodium - 15 mg

magnesium stearate - 5.25 mg

Film shell: hypromellose - 11.5728 mg

macrogol 1500 - 5.7812 mg

antifoaming emulsion SE2 - 0.015 mg

titanium dioxide (E171) - 1.626 mg

iron oxide red (E172) - 1.3 mg

talc - 0.72 mg

Indications

Dysfunctions of the brain, including age-related, associated with impaired cerebral circulation, accompanied by the following symptoms: memory impairment, decreased ability to concentrate and intellectual abilities, dizziness, tinnitus, headache.

Peripheral circulation disorders: obliterating diseases of the arteries of the lower extremities with such characteristic symptoms as: intermittent claudication, numbness and coldness of the feet, Raynaud's disease.

Inner ear problems with dizziness, unsteady gait, and tinnitus.

INN / Active ingredient

Ginkgo biloba leaf extract

Storage conditions and periods

At a temperature not higher than 30 degrees.

Expiration date: 5 years

Contraindications

Decreased blood clotting.

Erosive gastritis.

Peptic ulcer and duodenal ulcer in the acute phase.

Acute disorders of cerebral circulation.

Acute myocardial infarction.

Children under 12 years of age (data on use are insufficient).

Hypersensitivity to drug components.

Specifications

Scope of the drug

Neurology, psychiatry

Release form

Tablet

Manufacturer country

Germany

Package quantity, pcs

thirty

Scope of application

Neurology

,

Psychiatry

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Schwabe

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal angioprotective agent

Anatomical and therapeutic characteristics

N06DX02 Ginkgo Biloba leaf extract

Dosage form

Film-coated tablets

Packaging

Box

Expiration date in days

1826

The target audience

Adult

Package weight, g

45

Category

:

Mental strain

,

Memory impairment

,

Neuroprotective agents

,

Nootropic drugs

Mode of application

:

Inside, regardless of the time of the meal, without chewing, drinking a small amount of liquid.

Unless a different dosage regimen is prescribed, you should adhere to the recommendations listed below for taking the drug.

For symptomatic treatment of disorders of cerebral circulation: 40-80 mg 2-3 times a day.

The duration of the course of treatment is at least 8 weeks.

For peripheral circulatory disorders: 40 mg 3 times a day or 80 mg 2 times a day.

The duration of the course of treatment is at least 6 weeks.

For vascular and involutional pathology of the inner ear: 40 mg 3 times a day or 80 mg 2 times a day.

The duration of the course of treatment is 6–8 weeks.

Film-coated tablets, 120 mg - 1 tablet 1-2 times a day.

The duration of the course of treatment depends on the severity of the symptoms and is at least 8 weeks.

If there is no result after treatment within 3 months, the expediency of further treatment should be checked.

If the next dose was missed or an insufficient amount of the drug was taken, the next dose should be taken in accordance with the instructions.

Dosage (volume) of the substance in the preparation

:

dry standardized extract of ginkgo biloba leaves (EGb 761) (35-67: 1, extractant - acetone 60%) 80 mg